These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 15051931

  • 1. Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy.
    Lehfeld LS, Silveira LA, Ghini B, Lopes de Faria JB.
    Kidney Blood Press Res; 2004; 27(2):114-20. PubMed ID: 15051931
    [Abstract] [Full Text] [Related]

  • 2. Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus.
    Amazonas RB, Lopes de Faria JB.
    Life Sci; 2006 Oct 26; 79(22):2135-43. PubMed ID: 16890245
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
    Davis BJ, Cao Z, de Gasparo M, Kawachi H, Cooper ME, Allen TJ.
    J Hypertens; 2003 Jan 26; 21(1):209-16. PubMed ID: 12544453
    [Abstract] [Full Text] [Related]

  • 5. The presence of genetic hypertension stimulates early renal accumulation of fibronectin in experimental diabetes mellitus.
    Righetti AE, Boer-Lima PA, Lopes de Faria JB.
    Diabetologia; 2001 Nov 26; 44(11):2088-91. PubMed ID: 11719841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of hypertension with or without renin-angiotensin system inhibition precludes nephrin loss in the early stage of experimental diabetes mellitus.
    Amazonas RB, Sanita Rde A, Kawachi H, de Faria JB.
    Nephron Physiol; 2007 Nov 26; 107(2):p57-64. PubMed ID: 17890883
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M, Yasujima M, Kanazawa M, Yoshida K, Fu LP, Obara K, Saito T, Abe K.
    J Hypertens; 1995 Jan 26; 13(1):97-103. PubMed ID: 7759858
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive treatment in spontaneously hypertensive rats with streptozotocin-induced diabetes mellitus.
    Kusaka-Nakamura M, Kishi K, Miyazawa A, Yagi S, Sokabe H.
    Acta Physiol Hung; 1988 Jan 26; 71(2):251-69. PubMed ID: 3291554
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
    Lim AK, Ma FY, Nikolic-Paterson DJ, Ozols E, Young MJ, Bennett BL, Friedman GC, Tesch GH.
    Am J Nephrol; 2011 Jan 26; 34(4):337-46. PubMed ID: 21876346
    [Abstract] [Full Text] [Related]

  • 11. Effect of calcium channel blockade on adrenergically induced renal vasoconstriction in rat models of renal impairment.
    Khan AH, Sattar MA, Abdullah NA, Johns EJ.
    Clin Exp Pharmacol Physiol; 2009 May 26; 36(5-6):501-8. PubMed ID: 19673932
    [Abstract] [Full Text] [Related]

  • 12. Protective effects of a small dose of captopril on the reduction of glomerular basement membrane anionic sites in spontaneously hypertensive rats with streptozotocin-induced diabetes.
    Isogai S, Kameyama M, Iso K, Yoshino G.
    J Diabetes Complications; 1998 May 26; 12(3):170-5. PubMed ID: 9618073
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure and alpha-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca.
    Civantos B, Aleixandre A.
    Eur J Pharmacol; 2004 Apr 05; 489(1-2):101-10. PubMed ID: 15063161
    [Abstract] [Full Text] [Related]

  • 14. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
    Rumble JR, Doyle AE, Cooper ME.
    Am J Hypertens; 1995 Jan 05; 8(1):53-7. PubMed ID: 7734098
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Functional subtypes of renal alpha1-adrenoceptor in spontaneously hypertensive rats with streptozotocin-induced experimental diabetic nephropathy.
    Khan MA, Sattar MA, Abdullah NA, Abdulla MH, Salman IM, Kazi RN, Swarup KR, Rathore HA, Basri F, Hussain NM, Dewa A, Johns EJ.
    Kidney Blood Press Res; 2009 Jan 05; 32(5):349-59. PubMed ID: 19844130
    [Abstract] [Full Text] [Related]

  • 17. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug 05; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 18. Effects of antihypertensive agents on blood pressure and the progress of renal failure in partially nephrectomized spontaneously hypertensive rats.
    Katsumata H, Suzuki H, Ohishi A, Nakamoto H, Saruta T, Sakaguchi H.
    Lab Invest; 1990 Apr 05; 62(4):474-80. PubMed ID: 2185377
    [Abstract] [Full Text] [Related]

  • 19. Disparate effects of captopril on hypertension and blood vessel.
    Chen DG, Jin XQ, Wang HJ, Chen SC.
    Zhongguo Yao Li Xue Bao; 1996 Mar 05; 17(2):133-8. PubMed ID: 9772662
    [Abstract] [Full Text] [Related]

  • 20. Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril.
    Asdaq SM, Inamdar MN.
    Phytomedicine; 2010 Nov 05; 17(13):1016-26. PubMed ID: 20739164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.